申请人:Imperial College Of Science,
Technology And Medicine
公开号:EP3694866A1
公开(公告)日:2020-08-19
[EN] ITACONIC ACID DERIVATIVES AND USES THEREOF IN TREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE<br/>[FR] DÉRIVÉS D'ACIDE ITACONIQUE ET LEURS UTILISATIONS DANS LE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE OU D'UNE MALADIE ASSOCIÉE À UNE RÉPONSE IMMUNITAIRE INDÉSIRABLE
申请人:SITRYX THERAPEUTICS LTD
公开号:WO2020222011A1
公开(公告)日:2020-11-05
The invention relates to compounds of formula (IW-1) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: wherein RA, RB, RC and RD are as defined herein.
[EN] MAP4K4 INHIBITORS<br/>[FR] INHIBITEURS DE MAP4K4
申请人:IMPERIAL INNOVATIONS LTD
公开号:WO2019073253A1
公开(公告)日:2019-04-18
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).
including late-stage functionalization and radical cascade reactions. Furthermore, this technology could be extended to the construction of C–B, C–S and C–Sn bonds, thus offering a versatile platform for bond activation and connection of main group elements. The green aspect of the reaction has also been demonstrated by using Brij-30/water as a reaction solvent or sunlight as an alternative energy source